Thus, establishing the immuno-characteristics of WT1 over various astrocytic tumor grades and linking it to the diagnostic and prognostic biomarkers may need further investigation (Bourne et al., 2010; Kijima et al., 2014; Camacho-Urkaray et al., 2018; Manocha and Jain, 2019). The gene discussed is WT1; the disease is astrocytic tumor.